
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+5
Pliant Therapeutics is a late-stage biopharmaceutical company and leader in the discovery and development of novel therapeutics for the treatment of fibrotic diseases. At Pliant, we share a commitment and a clear passion to drive innovative science towards addressing areas of unmet medical need. Together we believe we have the power to make a difference in the lives of patients and those impacted by fibrotic diseases. We believe that by harnessing the therapeutic potential of integrin biology and TGF- modulation, there is a potential to create drug candidates aimed at halting or even reversing fibrotic diseases. Pliant recognizes the importance...
Fibrosis,integrins,muscle biology,oncology,duchenne muscular dystrophy,idiopathic pulmonary fibrosis,primary sclerosing cholangitis,muscular dystrophy,metabolic dysfunction-associated steatohepatitis,and mash
Pliant therapeutics operates in the Biotechnology research industry.
Pliant therapeutics's revenue is 11m - 100m
Pliant therapeutics has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.